Epidemiology and clinical presentation of hepatocellular carcinoma.

PubWeight™: 1.11‹?› | Rank: Top 10%

🔗 View Article (PMID 12354833)

Published in J Vasc Interv Radiol on September 01, 2002

Authors

Adrian M Di Bisceglie1

Author Affiliations

1: Division of Gastroenterology and Hepatology, Department of Internal Medicine, Saint Louis University School of Medicine, 3634 Vista Avenue, St. Louis, MO 63110, USA. dibiscam@slu.edu

Associated clinical trials:

Human Liver Explants for HIF-1 Alpha Analysis/Comparison (HIF HCC) | NCT00866957

Articles citing this

Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J Gastroenterol (2008) 3.34

Diagnosis of hepatocellular carcinoma. HPB (Oxford) (2005) 1.43

Irreversible electroporation of the liver and liver hilum in swine. HPB (Oxford) (2011) 1.38

An overview of HCV molecular biology, replication and immune responses. Virol J (2011) 1.37

Cyclooxygenases in hepatocellular carcinoma. World J Gastroenterol (2006) 1.31

Radiofrequency ablation of hepatocellular carcinoma: Current status. World J Radiol (2010) 1.31

Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region. Gut Liver (2016) 1.03

Protein kinase D negatively regulates hepatitis C virus secretion through phosphorylation of oxysterol-binding protein and ceramide transfer protein. J Biol Chem (2011) 1.02

A meta-analysis of occupational trichloroethylene exposure and liver cancer. Int Arch Occup Environ Health (2007) 0.85

Fucoxanthin enhances cisplatin-induced cytotoxicity via NFκB-mediated pathway and downregulates DNA repair gene expression in human hepatoma HepG2 cells. Mar Drugs (2013) 0.84

Radiofrequency ablation of cancer. Cardiovasc Intervent Radiol (2004) 0.83

Symptom management in hepatocellular carcinoma. Clin J Oncol Nurs (2008) 0.83

The management of hospitalized patients with cirrhosis: the Mount Sinai experience and a guide for hospitalists. Dig Dis Sci (2011) 0.82

SMAD7 loci contribute to risk of hepatocellular carcinoma and clinicopathologic development among Chinese Han population. Oncotarget (2016) 0.79

Silence of p15 expression by RNAi enhances cisplatin resistance in hepatocellular carcinoma cells. Bosn J Basic Med Sci (2012) 0.78

Perfusion reduction at transcatheter intraarterial perfusion MR imaging: a promising intraprocedural biomarker to predict transplant-free survival during chemoembolization of hepatocellular carcinoma. Radiology (2014) 0.77

Liver angiogenesis as a risk factor for hepatocellular carcinoma development in hepatitis C virus cirrhotic patients. World J Gastroenterol (2007) 0.77

Clinical Significance of Plasma Osteopontin Level as a Biomarker of Hepatocellular Carcinoma. Gastroenterology Res (2013) 0.75

Unusual Presentation of Hepatocellular Carcinoma into Right iliac fossa: A Rare Entity. J Clin Diagn Res (2015) 0.75